Wednesday 19 October 2022
Venue
Virtual via Microsoft Teams.
Present members
- Olivia Wu (Chair)
- Paul Charlton (Public Committee Member)
- Andrew Clegg
- Tony De Soyza
- Matthew Donati
- Antonieta Medina-Lara
- Catherine Moore
- Rupert Pearse
- James Wason
Secretariat
- Jason Horsley (Consultant Advisor)
- Vicky Taylor (Assistant Director, Applications and Funding)
- Helen Payne (Senior Research Manager)
- Abi Chalk (Assistant Research Manager)
Apologies
None.
Observers
- Mike Batley
- Julie McCarroll
- Nicola Williams
Quoracy information
- Voting members: 8 (Quoracy = 66% = 5)
- Voting members present: 8
22/124 A platform trial to evaluate therapeutic interventions for Influenza
NIHR155344 - RECOVERY-Influenza: a randomised, open label clinical trial of treatments for people hospitalised with influenza (Peter Horby, Oxford University)
Chair: Olivia Wu
Conflicts: None
Decision: Reject
NIHR155209 - A Randomised, Embedded, Multi-factorial, Adaptive Platform Trial for Community-Acquired Pneumonia (REMAP-CAP) – Influenza (Anthony Gordon, Imperial College London)
Chair: Olivia Wu
Conflicts: None
Decision: Fund with Changes